Clinical Trials Directory

Trials / Completed

CompletedNCT04441021

Feasibility Assessment of Risk Stratification and Oral Challenge in Hospitalized Children at Low Risk for Antibiotic Allergy

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Vanderbilt University Medical Center · Academic / Other
Sex
All
Age
0 Years
Healthy volunteers
Accepted

Summary

Children are often reported to have antibiotics allergies, with approximately 10% of the US population labeled as allergic to an antibiotic. Recent studies have demonstrated that a large majority of children with a penicillin allergy label do not have a true IgE-mediated allergy. Appropriately delabeling antibiotic allergies has been shown to improve patient care outcomes and lower health care costs. However, efforts to implement these assessments in practice are lacking, particularly in the hospital setting. Therefore, there is a need for hospital-based risk assessment and delabeling strategies for hospitalized children. The investigator's objective is to determine the feasibility of implementing a hospital-based approach to penicillin allergy risk stratification and evaluation of patients at low-risk for true allergy.

Conditions

Interventions

TypeNameDescription
OTHERPenicillin Allergy Risk Stratification and EvaluationThis standard of care intervention will provide an antibiotic allergy risk stratification assessment and subsequent amoxicillin oral challenge in patients who stratify as low risk for true allergy

Timeline

Start date
2020-09-15
Primary completion
2020-12-01
Completion
2021-06-29
First posted
2020-06-22
Last updated
2021-06-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04441021. Inclusion in this directory is not an endorsement.